Mahmoud Ghannoum

Dr. Mahmoud Ghannoum received an MSc in Medicinal Chemistry and his PhD in Microbial Physiology from the University of Technology in Loughborough, England, and an MBA from the Weatherhead School of Management at Case Western Reserve University, Cleveland, OH. Presently he is a tenured Professor and Director of the Center for Medical Mycology, Case Western Reserve University and University Hospitals Cleveland Medical Center. In that capacity, he established a multidisciplinary Center of Excellence that combines basic and translational research investigating medically important fungi from the test tube to the bedside. More recently, he pioneered studies on the fungal communities residing in our body and coined the term ‘Mycobiome”. He is also a Fellow of the Infectious Disease Society of America (IDSA) and past President of the Medical Mycological Society of the Americas (MMSA). In 2016, Dr Ghannoum received the Rhoda Benham Award from the MMSA, presented for his continuous outstanding and meritorious contributions to medical mycology. He also received the Freedom to Discover Award from Bristol-Myers Squibb for his work on microbial biofilms. In 2017, he was inducted as a Fellow of the American Academy of Microbiology. In addition to his academic career, Dr. Ghannoum is an entrepreneur-scientist who has launched a number of companies focused on the treatment of biofilm infections, as well as microbial dysbiosis as it relates to gut health.